Methylprednisolone and Epiglottitis - a phase IV clinical study of FDA data

Summary:

Epiglottitis is reported as a side effect among people who take Methylprednisolone (methylprednisolone), especially for people who are female, 50-59 old, also take Flovent, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Epiglottitis when taking Methylprednisolone. It is created by eHealthMe based on reports of 58,374 people who have side effects when taking Methylprednisolone from the FDA, and is updated regularly.

What is Methylprednisolone?

Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 59,645 Methylprednisolone users. Check the latest studies of Methylprednisolone.

What is Epiglottitis?

Epiglottitis (inflammation of the epiglottis) is found to be associated with 93 drugs and 281 conditions by eHealthMe. Check the latest studies of Epiglottitis.

On Jul, 25, 2026

58,374 people reported to have side effects when taking Methylprednisolone.
Among them, 21 people (0.04%) have Epiglottitis.

Could Methylprednisolone cause Epiglottitis?

Among these 21 people:

What is the gender of people who have Epiglottitis when taking Methylprednisolone? *

female: 90.48 %
male: 9.52 %

What is the age of people who have Epiglottitis when taking Methylprednisolone? *

What are other drugs people take besides Methylprednisolone? *

Acetaminophen: 14 people, 66.67%
Valacyclovir Hydrochloride: 14 people, 66.67%
Tecfidera: 14 people, 66.67%
Benadryl: 14 people, 66.67%
Flovent: 14 people, 66.67%
Tamsulosin: 13 people, 61.90%
Myrbetriq: 12 people, 57.14%
Mirabegron: 11 people, 52.38%
Ventolin: 8 people, 38.10%
Caffeine: 5 people, 23.81%

What are other side effects people have besides Epiglottitis? *

Neck Pain: 15 people, 71.43%
Oropharyngeal Pain: 15 people, 71.43%
Weakness: 14 people, 66.67%
Skin Disorder (skin disease): 14 people, 66.67%
Hypotension (abnormally low blood pressure): 14 people, 66.67%
Hot Flush (sudden feelings of heat): 14 people, 66.67%
Laryngitis (inflammation of the larynx): 14 people, 66.67%
Heart Rate Increased: 14 people, 66.67%
Headache (pain in head): 14 people, 66.67%
Fatigue (feeling of tiredness): 14 people, 66.67%

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 14 people, 66.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 14.29%
Respiratory Distress (difficulty in breathing): 1 person, 4.76%
Pneumonia Viral: 1 person, 4.76%
Interstitial Lung Disease: 1 person, 4.76%
Epstein-Barr Virus Infection: 1 person, 4.76%
Bladder Disorder: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Methylprednisolone and have Epiglottitis?

- Check whether Epiglottitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methylprednisolone:

Methylprednisolone (59,645 reports)

Epiglottitis treatments and more:

Epiglottitis (715 reports)

Browse all side effects of Methylprednisolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Epiglottitis:

Epiglottitis (93 drugs)

Browse all the conditions that are associated with Epiglottitis:

Epiglottitis (281 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone (the active ingredients of Methylprednisolone) and Methylprednisolone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.